Publications by authors named "Yu-Jia Ye"

Article Synopsis
  • The study focuses on Huanglian Wendan (HLWD), a traditional Chinese medicine, to treat metabolic-associated fatty liver disease (MAFLD) and atherosclerosis, both common health issues that often occur together.
  • Researchers aimed to identify the effective compounds in HLWD and understand how they work against MAFLD and atherosclerosis, using advanced techniques like ultrahigh-performance liquid chromatography and network analysis.
  • The results revealed 18 active components in HLWD and demonstrated that it effectively improves liver health and reduces body weight and blood lipids in a mouse model of MAFLD and atherosclerosis.
View Article and Find Full Text PDF

Pyrroline-5-carboxylate reductase (P5CR), an enzyme with conserved housekeeping roles, is involved in the etiology of cutis laxa. While previous work has shown that the R119G point mutation in the P5CR protein is involved, the structural mechanism behind the pathology remains to be elucidated. In order to probe the role of the R119G mutation in cutis laxa, we performed molecular dynamics (MD) simulations, essential dynamics (ED) analysis, and Molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) binding free energy calculations on wild type (WT) and mutant P5CR-NAD complex.

View Article and Find Full Text PDF

Pyrroline-5-carboxylate reductase (P5CR) encoded by PYCR1 gene is a housekeeping enzyme that catalyzes the reduction of P5C to proline using NAD(P)H as the cofactor. In this study, we used in silico approaches to examine the role of nonsynonymous single-nucleotide polymorphisms in the PYCR1 gene and their putative functions in the pathogenesis of Cutis Laxa. Among the 348 identified SNPs, 15 were predicted to be potentially damaging by both SIFT and PolyPhen tools; of them two SNP-derived mutations, R119G and G206W, have been previously reported to correlate with Cutis Laxa.

View Article and Find Full Text PDF